D2G Oncology

D2G Oncology is a precision-oncology company based in Mountain View, California, reported to have been founded in 2018 by Ian Winters. Public company descriptions characterize its work as applying quantitative and multiplexed functional cancer genomics to relate drugs to genotypes in order to advance precision cancer therapeutics. The company operates INSITE, a login-gated internal research portal at www.d2g-insite.com supporting preclinical study management and result exploration. D2G Oncology publishes no public developer API program, no developer portal, no API documentation, and no client SDKs, and third-party company trackers list the company as inactive as of 2026. It was surfaced through the Lightspeed Venture Partners portfolio and is retained here as an identity-only profile.

D2G Oncology is profiled on the APIs.io network. Tagged areas include Company, Oncology, Healthcare, Biotechnology, and Therapeutics.

🌐 Visit website 📡 Source on GitHub

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyOncologyHealthcareBiotechnologyTherapeuticsLife SciencesPrecision MedicineFunctional Genomics

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/d2g-oncology: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: d2g-oncology
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/d2g-oncology.png
name: D2G Oncology
description: D2G Oncology is a precision-oncology company based in Mountain View, California, reported to have been founded
  in 2018 by Ian Winters. Public company descriptions characterize its work as applying quantitative and multiplexed functional
  cancer genomics to relate drugs to genotypes in order to advance precision cancer therapeutics. The company operates INSITE,
  a login-gated internal research portal at www.d2g-insite.com supporting preclinical study management and result exploration.
  D2G Oncology publishes no public developer API program, no developer portal, no API documentation, and no client SDKs, and
  third-party company trackers list the company as inactive as of 2026. It was surfaced through the Lightspeed Venture Partners
  portfolio and is retained here as an identity-only profile.
url: https://raw.githubusercontent.com/api-evangelist/d2g-oncology/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: no-public-api-program
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Oncology
- Healthcare
- Biotechnology
- Therapeutics
- Life Sciences
- Precision Medicine
- Functional Genomics
apis: []
common:
- type: DomainSecurity
  url: security/d2g-oncology-domain-security.yml
- type: Website
  url: https://www.d2g-insite.com/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-notes:
  no-api-program: 'Enrichment pass 2026-07-20 found no public developer API surface: no developer portal, no documentation
    site, no consumer-facing OpenAPI/AsyncAPI/GraphQL, no first-party SDKs in npm, PyPI, Maven Central, NuGet, RubyGems, Packagist
    or crates.io, and no usable /.well-known artifacts. Every path probed on www.d2g-insite.com returns the single-page-app
    shell with HTTP 200 (soft 404), so security.txt, llms.txt, openid-configuration and api-catalog are all absent despite
    returning 200 status codes.'
  domain-warning: d2goncology.com is NO LONGER controlled by D2G Oncology. As of 2026-07-20 that domain serves an unrelated
    Dubai travel business (Andaleeb Travel Agency) and presents a TLS certificate valid only for *.web-hosting.com. Do not
    add it as a company property in future enrichment rounds. The only live company-controlled property found is www.d2g-insite.com.

D2G Oncology

Kin Score

Security Posture 1

D2G Oncology Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)